Category

Science

The latest published reporting in this category.

Business

Morning Post | Revealed that Ternus requested to speed up AI research and development/Win 11 optimizes the smoothness of 8GB memory computers/Musk: SpaceX’s annualized revenue may exceed US$500 billion in December next year

· Apple said that more than 100,000 applications have been adapted to iPhone Duo · Anthropic plans to launch an IPO road show this week · BYD Li Ke responded to Maserati acquisition rumors # Welcome to follow the official WeChat public account of Aifaner: Aifaner (WeChat ID: ifanr), more exciting content will be provided to you as soon as possible.

爱范儿
Read more
Science

The Guardian view on Ordnance Survey maps: still a superior way to navigate the landscape | Editorial

The 225th anniversary of the organisation’s first publication is an opportunity to celebrate its unique contribution to our sense of place In his one-paragraph short story, On Exactitude in Science, Jorge Luis Borges imagines an empire in which the level of cartographical ambition is so high that a map is made on a one-to-one scale with the imperial territory. The quest for perfect accuracy doesn’t end well. But the earliest map-makers for Ordnance Survey, which this week marked the 225th anniversary of its first publication, might have empathised with the obsessive dedication. The 1801 OS map

The Guardian
Read more
Science

Nasa seeks next generation of astronauts to live and work on the moon

Applications due on 3 December for new generation of explorers who can ‘shape humanity’s future in space’ Nasa has launched a callout for a new generation of astronauts as it searches for explorers who could live and work on the moon. Opening applications for the latest expansion of its Artemis program, the US agency said successful candidates would help “shape humanity’s future in space” as it builds a base on the moon and plans the first crewed missions to Mars. Continue reading...

The Guardian
Read more
Science

New drug could be cure for common cause of high blood pressure

Benefits of baxdrostat are unexpectedly found to remain up to two years after patients stop taking it Millions of people with high blood pressure stand to benefit from a new drug that has stunned doctors by reversing a common cause of the condition for years after patients stopped taking the medication. Patients who took the drug, called baxdrostat, saw their blood pressure improve during a six- to 12-month course of the daily pills, but unexpectedly the benefits remained up to two years later, with some patients no longer on any hypertension drugs and potentially cured of the condition. Conti

The Guardian
Read more